Rani Therapeutics
RANI
RANI
28 hedge funds and large institutions have $29.1M invested in Rani Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $34.5M → $29.1M (-$5.42M)
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$819K | |
| 2 | +$742K | |
| 3 | +$511K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$444K |
| 5 |
CCM
Crossvault Capital Management
San Antonio,
Texas
|
+$148K |
Top Sellers
| 1 | -$166K | |
| 2 | -$11.5K | |
| 3 | -$10.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.4K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.41K |